Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Semin Perinatol ; 47(8): 151837, 2023 12.
Article in English | MEDLINE | ID: mdl-37838485

ABSTRACT

Evidence is accumulating, both in the US and abroad, of the apparent serious health impacts of various environmental exposures tied to climate change. High ambient temperature, or heat, is a worsening global health risk. Heat risk is affected by many factors such as the magnitude, duration, and timing of exposure - such as specific, critical windows during pregnancy. This article focuses on the association of heat with both adverse pregnancy and newborn health outcomes. Regarding pregnancy, studies link heat and preterm birth, low birth weight and stillbirth. Multiple potential mechanisms support the biological plausibility of these associations. Emerging evidence suggests that heat, via epigenetics, may affect maternal health far beyond pregnancy. For newborn health impacts, heat is associated with increased hospitalization, neurologic and gastrointestinal dysfunction, and infant death. Research gaps include the need to study neonates separately from children and determining the mechanisms linking heat to adverse outcomes. We also highlight disparate adverse reproductive health outcomes for communities of color and low income tied to disproportionate exposures to environmental stressors like heat. Finally, we summarize educational and clinical tool resources for clinicians, information for patients, and opportunities for near-term action using the precautionary principle framework.


Subject(s)
Hot Temperature , Premature Birth , Pregnancy , Child , Female , Infant, Newborn , Humans , Infant Health , Stillbirth , Infant, Low Birth Weight
3.
Int J Gynaecol Obstet ; 155(3): 345-356, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34694628

ABSTRACT

Climate change is one of the major global health threats to the world's population. It is brought on by global warming due in large part to increasing levels of greenhouse gases resulting from human activity, including burning fossil fuels (carbon dioxide), animal husbandry (methane from manure), industry emissions (ozone, nitrogen oxides, sulfur dioxide), vehicle/factory exhaust, and chlorofluorocarbon aerosols that trap extra heat in the earth's atmosphere. Resulting extremes of weather give rise to wildfires, air pollution, changes in ecology, and floods. These in turn result in displacement of populations, family disruption, violence, and major impacts on water quality and availability, food security, public health and economic infrastructures, and limited abilities for civil society to maintain citizen safety. Climate change also has direct impacts on human health and well-being. Particularly vulnerable populations are affected, including women, pregnant women, children, the disabled, and the elderly, who comprise the majority of the poor globally. Additionally, the effects of climate change disproportionally affect disadvantaged communities, including low income and communities of color, and lower-income countries that are at highest risk of adverse impacts when disasters occur due to inequitable distribution of resources and their socioeconomic status. The climate crisis is tilting the risk balance unfavorably for women's sexual and reproductive health and rights as well as newborn and child health. Obstetrician/gynecologists have the unique opportunity to raise awareness, educate, and advocate for mitigation strategies to reverse climate change affecting our patients and their families. This article puts climate change in the context of women's reproductive health as a public health issue, a social justice issue, a human rights issue, an economic issue, a political issue, and a gender issue that needs our attention now for the health and well-being of this and future generations. FIGO joins a broad coalition of international researchers and the medical community in stating that the current climate crisis presents an imminent health risk to pregnant people, developing fetuses, and reproductive health, and recognizing that we need society-wide solutions, government policies, and global cooperation to address and reduce contributors, including fossil fuel production, to climate change.


Subject(s)
Air Pollution , Climate Change , Aged , Air Pollution/statistics & numerical data , Animals , Female , Humans , Leadership , Pregnancy , Public Health , Women's Health
4.
Article in English | MEDLINE | ID: mdl-32977683

ABSTRACT

Climate change is a global threat that poses significant risks to pregnant women and to their developing fetus and newborn. Educating pregnant women about the risks to their pregnancy may improve maternal and child health outcomes. Prior research suggests that presenting health information in narrative format can be more effective than a didactic format. Hence, the purpose of this study was to test the effectiveness of two brief educational interventions in a diverse group of pregnant women (n = 151). Specifically, using a post-test only randomized experiment, we compared the effectiveness of brief information presented in a narrative format versus a didactic format; both information formats were also compared to a no information control group. Outcome measures included pregnant women's actual and perceived knowledge, risk perception, affective assessment, self-efficacy, intention to take protective behaviors, and subsequent information seeking behavior. As hypothesized, for all outcome measures, the narrative format was more effective than the didactic format. These results suggest the benefits of a narrative approach (versus a didactic approach) to educating pregnant women about the maternal and child health threats posed by climate change. This study adds to a growing literature on the effectiveness of narrative-based approaches to health communication.


Subject(s)
Climate Change , Health Education/methods , Health Knowledge, Attitudes, Practice , Information Seeking Behavior , Patient Education as Topic/methods , Pregnant Women/psychology , Self Efficacy , Adult , Female , Humans , Infant, Newborn , Outcome Assessment, Health Care , Perception , Pregnancy , Pregnant Women/education
5.
Obstet Gynecol Clin North Am ; 47(3): 497-502, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32762934

ABSTRACT

The use of telehealth is gaining momentum in providing obstetric care. Telehealth through various platforms provides obstetricians and gynecologists and other providers of obstetric and postpartum care with the tools to better facilitate prenatal, intrapartum, and postpartum encounters. Telehealth helps facilitate consultation with specialists and subspecialists in maternal-fetal medicine in a team-based fashion to improve quality and safe obstetric practices in a fragmented obstetric care delivery system, especially in rural access communities. Telehealth can be beneficial especially in the postpartum period for breastfeeding and lactation assistance and for postpartum depression follow-up.


Subject(s)
Maternal Health Services , Telemedicine/methods , Breast Feeding , Delivery of Health Care , Female , Gynecology , Humans , Obstetrics , Postnatal Care , Pregnancy , Prenatal Care , Referral and Consultation , Rural Population , United States
6.
JAMA Netw Open ; 3(6): e208243, 2020 06 01.
Article in English | MEDLINE | ID: mdl-32556259

ABSTRACT

Importance: Knowledge of whether serious adverse pregnancy outcomes are associated with increasingly widespread effects of climate change in the US would be crucial for the obstetrical medical community and for women and families across the country. Objective: To investigate prenatal exposure to fine particulate matter (PM2.5), ozone, and heat, and the association of these factors with preterm birth, low birth weight, and stillbirth. Evidence Review: This systematic review involved a comprehensive search for primary literature in Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, PubMed, ClinicalTrials.gov website, and MEDLINE. Qualifying primary research studies included human participants in US populations that were published in English between January 1, 2007, and April 30, 2019. Included articles analyzed the associations between air pollutants or heat and obstetrical outcomes. Comparative observational cohort studies and cross-sectional studies with comparators were included, without minimum sample size. Additional articles found through reference review were also considered. Articles analyzing other obstetrical outcomes, non-US populations, and reviews were excluded. Two reviewers independently determined study eligibility. The Arskey and O'Malley scoping review framework was used. Data extraction was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Findings: Of the 1851 articles identified, 68 met the inclusion criteria. Overall, 32 798 152 births were analyzed, with a mean (SD) of 565 485 (783 278) births per study. A total of 57 studies (48 of 58 [84%] on air pollutants; 9 of 10 [90%] on heat) showed a significant association of air pollutant and heat exposure with birth outcomes. Positive associations were found across all US geographic regions. Exposure to PM2.5 or ozone was associated with increased risk of preterm birth in 19 of 24 studies (79%) and low birth weight in 25 of 29 studies (86%). The subpopulations at highest risk were persons with asthma and minority groups, especially black mothers. Accurate comparisons of risk were limited by differences in study design, exposure measurement, population demographics, and seasonality. Conclusions and Relevance: This review suggests that increasingly common environmental exposures exacerbated by climate change are significantly associated with serious adverse pregnancy outcomes across the US.


Subject(s)
Air Pollution/statistics & numerical data , Hot Temperature , Infant, Low Birth Weight , Premature Birth/epidemiology , Stillbirth/epidemiology , Female , Humans , Maternal Exposure/statistics & numerical data , Observational Studies as Topic , Pregnancy , United States
7.
Obstet Gynecol Clin North Am ; 47(2): 317-331, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32451020

ABSTRACT

Mobile apps and mobile health interventions have the potential to alter the landscape of medicine significantly, from how care is provided at the bedside to the ability to recruit patients and conduct medical research. Mobile apps have the potential to be used for prenatal care, postsurgical follow-ups, informing patients about conditions, and helping with the management of illness. They have the ability to remodel prenatal care and strive toward more personalized medicine. The most remote and vulnerable patients can be reached. Guidelines must be created, however, for optimal use of mobile health apps and a structured way to vet them.


Subject(s)
Gynecology , Mobile Applications , Obstetrics , Telemedicine/methods , Contraception , Female , Fertility , Humans , Menopause , Menstrual Cycle , Postnatal Care , Pregnancy , Prenatal Care , Women's Health Services
8.
Obstet Gynecol ; 135(2): 371-382, 2020 02.
Article in English | MEDLINE | ID: mdl-31977782

ABSTRACT

OBJECTIVE: To systematically review the effectiveness of telehealth interventions for improving obstetric and gynecologic health outcomes. DATA SOURCES: We conducted a comprehensive search for primary literature in ClinicalTrials.gov, Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. METHODS OF STUDY SELECTION: Qualifying primary studies had a comparison group, were conducted in countries ranked very high on the United Nations Human Development Index, published in English, and evaluated obstetric and gynecologic health outcomes. Cochrane Collaboration's tool and ROBINS-I tool were used for assessing risk of bias. Summary of evidence tables were created using the United States Preventive Services Task Force Summary of Evidence Table for Evidence Reviews. TABULATION, INTEGRATION, RESULTS: Of the 3,926 published abstracts identified, 47 met criteria for inclusion and included 31,967 participants. Telehealth interventions overall improved obstetric outcomes related to smoking cessation and breastfeeding. Telehealth interventions decreased the need for high-risk obstetric monitoring office visits while maintaining maternal and fetal outcomes. One study found reductions in diagnosed preeclampsia among women with gestational hypertension. Telehealth interventions were effective for continuation of oral and injectable contraception; one text-based study found increased oral contraception rates at 6 months. Telehealth provision of medication abortion services had similar clinical outcomes compared with in-person care and improved access to early abortion. Few studies suggested utility for telehealth to improve notification of sexually transmitted infection test results and app-based intervention to improve urinary incontinence symptoms. CONCLUSION: Telehealth interventions were associated with improvements in obstetric outcomes, perinatal smoking cessation, breastfeeding, early access to medical abortion services, and schedule optimization for high-risk obstetrics. Further well-designed studies are needed to examine these interventions and others to generate evidence that can inform decisions about implementation of newer telehealth technologies into obstetrics and gynecology practice.


Subject(s)
Gynecology/methods , Obstetrics/methods , Telemedicine/methods , Female , Gynecology/trends , Humans , Obstetrics/trends , Pregnancy , Prenatal Care/standards , Quality of Health Care , Randomized Controlled Trials as Topic , Telemedicine/trends
9.
Obstet Gynecol Clin North Am ; 46(3): 455-468, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31378288

ABSTRACT

Our genetic makeup and environment interact. Evidence has emerged demonstrating preconception and prenatal exposure to toxic agents have a profound effect on reproductive health. We cannot change our genetics, but we can change our environment. Health providers can protect pregnancies from harmful exposures. Pregnancy is the most critical time-window for human development, when any toxic exposure can cause lasting damage to brain development. Reproductive care professionals can provide useful information to patients and refer patients to appropriate specialists when hazardous exposure is identified. Clinical experience and expertise in communicating risks of treatment are transferable to environmental health.


Subject(s)
Environmental Exposure/adverse effects , Fetal Development/drug effects , Maternal-Fetal Exchange , Reproductive Health , Counseling , Female , Halogenated Diphenyl Ethers/toxicity , Humans , Lead/toxicity , Mercury/toxicity , Neurodevelopmental Disorders/chemically induced , Organophosphates/toxicity , Polychlorinated Biphenyls/toxicity , Pregnancy , Women's Health
11.
Int J Gynaecol Obstet ; 131(3): 219-25, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26433469

ABSTRACT

Exposure to toxic environmental chemicals during pregnancy and breastfeeding is ubiquitous and is a threat to healthy human reproduction. There are tens of thousands of chemicals in global commerce, and even small exposures to toxic chemicals during pregnancy can trigger adverse health consequences. Exposure to toxic environmental chemicals and related health outcomes are inequitably distributed within and between countries; universally, the consequences of exposure are disproportionately borne by people with low incomes. Discrimination, other social factors, economic factors, and occupation impact risk of exposure and harm. Documented links between prenatal exposure to environmental chemicals and adverse health outcomes span the life course and include impacts on fertility and pregnancy, neurodevelopment, and cancer. The global health and economic burden related to toxic environmental chemicals is in excess of millions of deaths and billions of dollars every year. On the basis of accumulating robust evidence of exposures and adverse health impacts related to toxic environmental chemicals, the International Federation of Gynecology and Obstetrics (FIGO) joins other leading reproductive health professional societies in calling for timely action to prevent harm. FIGO recommends that reproductive and other health professionals advocate for policies to prevent exposure to toxic environmental chemicals, work to ensure a healthy food system for all, make environmental health part of health care, and champion environmental justice.


Subject(s)
Environmental Exposure/adverse effects , Environmental Pollutants/adverse effects , Prenatal Exposure Delayed Effects/epidemiology , Reproduction/drug effects , Breast Feeding , Cost of Illness , Environmental Exposure/prevention & control , Environmental Monitoring/methods , Female , Global Health , Humans , International Agencies , Pregnancy , Prenatal Exposure Delayed Effects/prevention & control , Risk Factors , Socioeconomic Factors
12.
Curr Opin Obstet Gynecol ; 26(6): 495-502, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25377439

ABSTRACT

PURPOSE OF REVIEW: To chronicle a medical professional society's adoption of innovation and to describe themes pertinent to the adoption. RECENT FINDINGS: In September 2013, the American College of Obstetricians and Gynecologists (ACOG) published a Committee Opinion on Toxic Environmental Agents that included an infographic and social media awareness campaign. To date, it claims one of the highest total audience reaches for an ACOG Facebook post reaching nearly 18 000 viewers. Despite this powerful promise, ACOG's timely and successful social media campaign did not always appear an obvious strategy. Although social media took hold of popular culture in the early 2000s, social media's professional etiquette remained uncharted and rife, with cautionary tales through the latter half of the decade. SUMMARY: Through a thoughtful and dedicated process, the ACOG Fellow and Junior Fellow leadership partnered to navigate the appropriate balance of innovation and prudence that propelled ACOG into social media's golden age, and paved the pathway for more progressive institutional changes.


Subject(s)
Consumer Health Information , Gynecology/history , Obstetrics/history , Patient Advocacy , Social Media/statistics & numerical data , Societies, Medical/history , Women's Health , Consumer Health Information/trends , Female , Gynecology/education , History, 21st Century , Human Rights/education , Humans , Leadership , Male , Obstetrics/education , Organizational Innovation , Patient Advocacy/trends , United States , Women's Health/education , Workforce
13.
J Perinat Med ; 40(1): 51-5, 2011 Nov 02.
Article in English | MEDLINE | ID: mdl-22044007

ABSTRACT

OBJECTIVE: To evaluate the possible association between protease inhibitor (PI) and premature birth and low birth-weight in HIV-infected pregnancies. MATERIALS AND METHODS: Data were collected retrospectively for maternal and pregnancy characteristics, antiretroviral medication, lowest CD4 count and highest viral load during pregnancy, and pregnancy outcomes. χ(2) Analysis, Student's t-test, and multiple logistic regression analysis were performed. RESULTS: Data from 161 HIV-infected women who delivered singleton gestation were analyzed. Fifty-three received an antepartum regimen with PI, 84 received a regimen without PI, and six did not receive antepartum treatment. The mean estimated gestational age (EGA)± SD at delivery was 37.7 ± 3.2 weeks. The premature birth rate was 18.4%. No difference was detected between women receiving the antiretroviral regimen including PI and those on the regimen without PI or on no antepartum medication with regard to: EGA ± SD at delivery (37.7 ± 3.2 vs. 37.6 ± 3.1 weeks, respectively, P=0.87), rate of premature birth (14% vs. 20.6%, respectively, P=0.32) and low birth-weight (12.5% vs. 20.2%, respectively, P=0.25). In multiple logistic regression analysis, PI was not associated with premature birth or low birth-weight. CONCLUSION: Women receiving antiretroviral therapy with PI have a similar rate of premature birth and low birth-weight as women receiving antiretroviral therapy without PI or on no medication.


Subject(s)
Antiretroviral Therapy, Highly Active , Birth Weight/drug effects , HIV Infections/drug therapy , Pregnancy Complications, Infectious/drug therapy , Premature Birth/chemically induced , Protease Inhibitors/adverse effects , Adult , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Pregnancy , Retrospective Studies , Young Adult
14.
J Matern Fetal Neonatal Med ; 24(1): 73-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20459338

ABSTRACT

OBJECTIVE: To determine the frequency of immediate morbidities in neonates with evidence of mature fetal lung indices who delivered before 37 weeks gestation. METHODS: A retrospective analysis was performed on pregnancies resulting in birth at < 37 weeks after mature fetal lung was documented by phosphatidylglycerol, lecithin/sphingomyelin ratio, or TDx-FLM studies. Pregnancies with multifetal gestations, maternal diabetes, or fetal anomalies were excluded. RESULTS: 179 patients were included. Eighty-one (45.3%) neonates did not sustain any morbidity, and 98 (54.7%) neonates sustained one or more morbidities. Compared to neonate without any morbidity, neonates experiencing morbidities were delivered at significantly younger gestation (35.7 ± 1.1 vs. 34.9 ± 1.5 weeks, respectively, p < 0.001) had lower birth- weight (2632.2 ± 475.5 vs. 2395.3 ± 496 g, respectively, p < 0.001), and required longer hospital stay (3.7 ± 2.8 vs. 6.9 ± 7.5 days, p < 0.001). A multivariate regression model was performed to control for the effect of birth-weight, steroid administration, and preterm premature rupture of membrane. An earlier gestational age at delivery was associated with a higher risk of neonatal morbidity. The risk of neonatal morbidity decreased by 40% (OR = 0.60, 95% CI = 0.41-0.88; p = 0.009) for each 1 week increase in gestational age. CONCLUSION: Even in the presence of documented fetal lung maturity, major morbidities--including respiratory distress - may still occur.


Subject(s)
Fetal Organ Maturity , Premature Birth/epidemiology , Adult , Female , Humans , Lung/embryology , New Orleans/epidemiology , Pregnancy , Retrospective Studies , Young Adult
15.
J Natl Med Assoc ; 102(12): 1158-64, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21287896

ABSTRACT

OBJECTIVE: To describe the obstetrical characteristics of women without prenatal care and/or undocumented human immunodeficiency virus (HIV) serostatus who presented for delivery and to assess the usefulness of rapid HIV screening in these women. MATERIALS AND METHODS: The study design was a retrospective analysis. Demographics, labor, delivery characteristics, and pregnancy outcomes of women without prenatal care and/or unknown HIV serostatus were reviewed. RESULTS: Three hundred fifty parturients met the inclusion criteria: 15.2% presented at complete cervical dilation, 48.6% with cervical dilation of at least 5 cm, and 43.1% with ruptured membranes. Twenty-two percent of parturients delivered within 1 hour of admission, 47.6% delivered within 4 hours of admission, and 5.5% delivered prior to arrival to the hospital. With the lengthy admission process and procurement of zidovudine from the pharmacy requiring at least 1 hour at best, 27.5% would not have the benefit of intrapartum zidovudine treatment. Single Use Diagnostic System HIV-1 rapid test was reactive and confirmed in 7 women (2.5%). CONCLUSION: Rapid HIV screening is a useful tool for guiding immediate obstetrical management and coordinated care for the neonate. In some circumstances, the full benefit of rapid HIV detection will not be realized due to advanced labor, ruptured members, or delivery prior to arrival.


Subject(s)
AIDS Serodiagnosis/methods , HIV Infections/diagnosis , Pregnancy Complications, Infectious/diagnosis , Adolescent , Adult , Blotting, Western , Chi-Square Distribution , Delivery, Obstetric , Female , HIV Infections/transmission , Humans , Infectious Disease Transmission, Vertical/prevention & control , Labor, Obstetric , Louisiana , Mass Screening/methods , Pregnancy , Retrospective Studies
16.
Fetal Diagn Ther ; 23(3): 245-8, 2008.
Article in English | MEDLINE | ID: mdl-18417986

ABSTRACT

INTRODUCTION: Organic acids were examined from normal and Down syndrome pregnancies to identify possible differences between the amniotic fluid from fetuses with Down Syndrome compared with that of normal fetuses. MATERIALS AND METHODS: Amniotic fluids were obtained from prior amniocenteses. Forty-one normal and 22 Down syndrome specimens were assayed using gas chromatography/mass spectrometry. RESULTS AND DISCUSSION: 5-hydroxycaproate, methylsuccinate, alpha-ketoglutarate, and adipate were significantly elevated in Down syndrome, suggesting riboflavin deficiency. Phenylpyruvate was also significantly elevated in fetuses with Down syndrome. Phenylpyruvate inhibits the metabolism of tetrahydrobiopterin, which is necessary for neurotransmitter metabolism. Elevated phenylpyruvate is consistent with previous research, suggesting a disturbance of tetrahydrobiopterin metabolism in Down syndrome. CONCLUSION: Organic acid markers for B2 deficiency are elevated in the amniotic fluid of fetuses with Down syndrome. Elevation of phenylpyruvate may impair neurotransmitter metabolism. Organic acid markers for B12 levels are not different between the Down syndrome and normal group.


Subject(s)
Amniotic Fluid/metabolism , Carboxylic Acids/metabolism , Down Syndrome/diagnosis , Down Syndrome/metabolism , Amniocentesis , Biomarkers/metabolism , Case-Control Studies , Female , Gas Chromatography-Mass Spectrometry , Humans , Metabolism, Inborn Errors/diagnosis , Metabolism, Inborn Errors/metabolism , Phenylpyruvic Acids/metabolism , Pregnancy , Prenatal Diagnosis , Riboflavin Deficiency/diagnosis , Riboflavin Deficiency/metabolism
17.
Fetal Diagn Ther ; 23(4): 254-7, 2008.
Article in English | MEDLINE | ID: mdl-18417989

ABSTRACT

INTRODUCTION: Some studies of children with Down syndrome have found mild abnormalities in the metabolism of pyridoxine (vitamin B(6)); therefore the present question is whether such abnormalities might also be present in the amniotic fluid of fetuses with Down syndrome. MATERIALS AND METHODS: Archived specimens of amniotic fluid were obtained from chromosomally normal and from fetuses with Down syndrome. Gas chromatography/mass spectrometry quantitized B-related metabolites, including oxalate, xanthurenate, kynurenine and 4-pyridoxic acid. RESULTS: Oxalate, a marker of pyridoxine deficiency, was elevated in the amniotic fluid of fetuses with Down syndrome. This result was statistically significant. The other marker results were not statistically significant. CONCLUSION: A marker of pyridoxine deficiency, oxalate is elevated in the amniotic fluid of fetuses with Down syndrome. These results in amniotic fluid are consistent with previous studies done in the urine of young children.


Subject(s)
Amniotic Fluid/metabolism , Down Syndrome/metabolism , Pyridoxine/metabolism , Biomarkers/metabolism , Case-Control Studies , Down Syndrome/diagnosis , Female , Humans , Kynurenine/metabolism , Oxalic Acid/metabolism , Pregnancy , Prenatal Diagnosis , Pyridoxic Acid/metabolism , Retrospective Studies , Xanthurenates/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...